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Background: Active, population-wide mass screening and treatment (MSAT) for chronic Plasmodium falciparum
carriage to eliminate infectious reservoirs of malaria transmission have proven difficult to apply on large national
scales through trained clinicians from central health authorities.
Methodology: Fourteen population clusters of approximately 1,000 residents centred around health facilities (HF)
in two rural Zambian districts were each provided with three modestly remunerated community health workers
(CHWs) conducting active monthly household visits to screen and treat all consenting residents for malaria
infection with rapid diagnostic tests (RDT). Both CHWs and HFs also conducted passive case detection among
residents who self-reported for screening and treatment.
Results: Diagnostic positivity was higher among symptomatic patients self-reporting to CHWs (42.5%) and HFs (24%)
than actively screened residents (20.3%), but spatial and temporal variations of diagnostic positivity were highly
consistent across all three systems. However, most malaria infections (55.6%) were identified through active home visits
by CHWs rather than self-reporting to CHWs or HFs. Most (62%) malaria infections detected actively by CHWs reported
one or more symptoms of illness. Most reports of fever and vomiting, plus more than a quarter of history of fever,
headache and diarrhoea, were attributable to malaria infection. The minority of residents who participated >12 times
had lower rates of malaria infection and associated symptoms in later contacts but most residents were tested <4 times
and high malaria diagnostic positivity (32%) in active surveys, as well as incidence (1.7 detected infections per person
per year) persisted in the population. Per capita cost for active service delivery by CHWs was US$5.14 but this would
rise to US$10.68 with full community compliance with monthly testing at current levels of transmission, and US$6.25 if
pre-elimination transmission levels and negligible treatment costs were achieved.
Conclusion: Monthly active home visits by CHWs equipped with RDTs were insufficient to eliminate the human
infection reservoir in this typical African setting, despite reasonably high LLIN/IRS coverage. However, dramatic impact
upon infection and morbidity burden might be attainable and cost-effective if community
participation in regular testing could be improved and the substantial, but not necessarily prohibitive, costs are
affordable to national programmes.
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A relatively large proportion of malaria infections are
only mildly symptomatic, especially in endemic coun-
tries where acquired immunity moderates both parasit-
aemia and pathology [1-3]. Even in areas with only
modest, seasonally sporadic transmission where little im-
munity exists among the human populations, the many
mildly symptomatic infections that persist chronically,
often at sub-patent parasite densities below thresholds
of detectability, are responsible for sustained malaria
transmission [4,5]. As early as the 1930s, these popula-
tions have been targeted for treatment with anti-malarial
drugs as a control measure for malaria transmission, par-
ticularly during the era of the Global Malaria Eradication
Programme initiated in the 1950s [6-8]. Due to the
emergence of drug resistance, which was attributed to
mass drug administration campaigns [9-11] and evi-
dence that the impact on transmission may be limited,
the use of therapeutic approaches to control transmis-
sion rather than burden was not considered as effective
[6,8,12,13] until recently, when interest in malaria elim-
ination was rejuvenated [13-15].
Currently curative drugs are predominantly targeted at
symptomatic individuals based on passive detection of
acute infections among patients seeking care for fevers
through the formal and informal health system [16-18].
Strategies for control of human-to-mosquito transmission
by providing chemotherapy to chronic parasite carriers are
now being revisited as they may be complimentary to
front-line interventions for preventing mosquito-to-human
transmission, such as long-lasting insecticidal nets
(LLINs) and indoor residual spraying (IRS) of houses, to
further accelerate declines in malaria burden [19-21] in
areas of low and seasonal transmission [8,13,22].
However, most of the infected fraction of the human
population only exhibits sub-acute symptoms so they do
not always obtain medical care, even where it is readily
available [23,24]. These carriers of chronic, mildly symp-
tomatic malaria infection thus act as the silent reservoir
of infection because even low, often sub-patent levels of
parasitaemia are sufficient to infect mosquitoes [25-27].
Additionally, asymptomatic individuals risk developing
chronic anaemia and symptomatic malaria [28,29]. Across
all levels of transmission, the majority of infections and
onward transmission to mosquitoes occurs in older age
groups, even though the young often harbour the highest
parasite densities, because the former comprise the bulk
of the human population and vector biting rates increase
with host biomass and therefore age [20,30,31]. In such
populations, many individuals remain parasitaemic and in-
fectious for one or more years [32-34]. Thus, in order to
eliminate human-to-mosquito transmission with thera-
peutic drugs, all cryptic or asymptomatic infections within
a human population must be successfully terminated,necessitating comprehensive coverage of targeted commu-
nities [20,21,28,35].
Essentially two broad strategies for taking malaria
chemotherapy beyond routine case management have
been described: mass drug administration (MDA) or
mass screening & treatment (MSAT), historically re-
ferred to as mass blood examination [20,36]. MDA en-
tails administering anti-malarials to every traceable
consenting member of a population, regardless of
whether their malaria infection status is known or
whether they exhibit symptoms [13,20,36], while MSAT
targets only confirmed parasitaemic individuals after
parasitological testing for infection status [20,36]. MDA
necessitates comprehensive coverage and failure may ac-
celerate the spread of drug-resistant strains selected by
strong but incomplete selection pressure on the parasite
populations [37,38]. MSAT has been proposed as a bet-
ter alternative because treatment is limited to those
diagnostically confirmed to be infected, thus lowering
treatment costs and risks of selection for resistance
[39,40]. However, the major limitation of MSAT lies in
the challenge of detecting low-density infections, which
contribute substantially to the reservoir of infection [40].
With increasing availability of more sensitive, scalable
malaria rapid diagnostic tests (RDTs) that can be used
by non-specialist community based health workers in
low-resource settings, MSAT is now logistically feasible
[38,39,41,42].
The concept of community-based management of
malaria stems from the recognition that human resource
deficits amongst clinically-trained professional cadres
are commonplace, so extending service delivery beyond
centralized health facilities, by mobilizing through com-
munity health workers (CHW) will be required to improve
access to appropriate management of uncomplicated mal-
aria [43,44]. CHWs have demonstrated the capacity to
effectively diagnose malaria with RDTs and provide treat-
ment according to the locally relevant policy and guide-
lines [41,42,45,46]. The community-based diagnosis and
treatment approach has also been shown to be cost-
effective [47,48], improve delivery of malaria case manage-
ment overall [49-51], is well accepted by communities
[52-54] and also provides a potentially valuable popula-
tion–wide platform for monitoring trends in human para-
sitaemia [55].
However, this approach remains grossly underutilized
and understudied, with only 15 million RDTs utilized at
community level globally, mostly in India [56]. This
study therefore evaluated the effectiveness of paid
CHWs providing improved access to blood screening
and treatment services to community members, not
only when they self-reported because they felt ill, but
also through regular monthly active visits to their
homes.
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Study areas
The study was conducted in two adjacent rural districts
of Zambia, Luangwa District in Lusaka province and
Nyimba District in Eastern province (Figure 1) where
perennial transmission of Plasmodium falciparum is
predominantly mediated by Anopheles funestus [57,58]
at an entomologic inoculation rate (EIR) of approxi-
mately 70 infectious bites per unprotected person per
year (Sikaala CH, Chinula D, Chanda J, Hamainza B,
Mwenda M, Mukali I, Kamuliwo M, Lobo N, Seyoum A
and Killeen GF, personal communication).Figure 1 Map indicating location of health facilities and associated caNyimba is located 350 kilometres east of the capital
city Lusaka and covers an area of 10,943 km2 with a
population of approximately 86,000 residents, most of
whom are involved in agriculture as their main liveli-
hood. Nyimba is drained by three perennial rivers the
Luangwa and its two tributaries the Lunsemfwa and the
Lukusashi, as well several streams. Nyimba spans a range
of altitudes from 400 m to 1,200 m along the Luangwa
valley with temperatures averaging 30°C and mean an-
nual rainfall of 1,000 mm [59]. The population of
Nyimba is served by 17 health centres and one first-level
hospital located in the centre of Nyimba town.tchment populations enrolled in the study.
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Zambezi and Luangwa rivers, 325 kilometres south-east
of Lusaka. The population of the Luangwa is 25,000 resi-
dents, most of whom are settled along the river where
the main economic activities are fishing and agriculture.
The district covers a surface area of 3,468 km2 and lies
350 to 500 metres above sea level. Luangwa has an aver-
age temperature in above 35°C and a mean annual rain-
fall of approximately 800 mm [59]. Luangwa has nine
health centres, of which two have inpatient services, one
of which is located in the district central business area at
Luangwa Boma and another at Katondwe Mission lo-
cated about 40 km further north.
Community health workers
In Zambia, community health workers (CHWs) are a
formally accepted part of the health service delivery sys-
tem and are selected by the communities they serve. In
order to qualify, they must reside within the community,
be literate in English, and be available and willing to pro-
vide basic care to their communities. Once selected, they
are trained for a period of six weeks in basic primary
healthcare, mainly focusing on aspects of prevention and
treatment of common ailments as part of their health
promotion duties. The major disease focus areas are the
simple forms of malaria, pneumonia and diarrhoea.
When care is sought from the CHWs, the patient’s
symptoms are assessed and the CHWs follow the guide-
lines for diagnosis and treatment. The CHWs are also
trained how to recognize clinical danger signs and facili-
tate referral of these cases to the HFs for further man-
agement [60]. Each CHW is attached to the HF nearest
to their community and is normally responsible for
approximately 500 of the resident inhabitants. The
clinically-trained HF staff are responsible for supervising
and mentoring the CHWs, and for supplying all their
equipment and consumables. The CHWs that partici-
pated in this study were selected from available CHWs
in their specific catchment areas and recruited through
their supervising HFs. These recruited CHWs were re-
munerated at a rate of 350 Zambian Kwacha (approxi-
mately US$71.58) per month. A total of three CHWs per
cluster (42 active CHWs) were selected to participate in
the study and re-trained for a week in malaria diagnosis
(use and interpretation of RDTs), treatment (prescription
and dosage of AL), referral procedures (recognition of
danger signs) and reporting.
Study design
This longitudinal study was conducted, from January to
December 2011. In each study district, seven clusters of
approximately 165 consenting households (average num-
ber of resident members per household was estimated at
approximately six [61], each of which was selected andenrolled in order of proximity to the public-sector HF
that defined the centre of the cluster. All members of
the household were eligible to participate except preg-
nant women and children below six months of age. The
exclusion of these groups was stipulated in accordance
with national guidelines that CHWs are not allowed to
manage any condition in these select groups. Each clus-
ter received the standard Ministry of Health interven-
tions for malaria control in Zambia, which included
long-lasting insecticidal nets (LLINs), diagnosis by either
microscopy or rapid diagnostic tests (RDTs), treatment
with artemether-lumefantrine (AL) and intermittent pre-
sumptive treatment with sulphadoxine-pyrimethamine.
The LLINs were distributed through mass distribution
campaigns in 2006, 2008 and again 2009 [62], following
a project-based distribution to selected villages in
Luangwa in 2005 [63] and routine delivery for pregnant
women and under five children through the antenatal
clinics at each of the health facilities in the study [64,65].
Intermittent presumptive therapy in pregnancy IPTp)
was also routinely provided through the antenatal clinics
with a target of 3 doses during each pregnancy [64,65].
Data collection
Each CHW recorded all patient diagnoses and responses
to pre-set questions in a malaria register book which de-
tailed RDT outcomes, as well as details of age, symp-
toms, use of IPTp or LLINs, and treatment of their
house with IRS in the previous six months. Information
on access and use of interventions was collected at an
individual level among all participants for those who
gave consent to participate in the study. Active case de-
tection was achieved through monthly home visits by
the CHWs to each enrolled household within their
assigned catchment areas, during which all consenting
and assenting members were screened for malaria infec-
tion using HRP2-based RDTs from ICT Diagnostics
(ICT Malaria Pf cassette test). Between these visits, pas-
sive case detection was accomplished by encouraging
those who had symptoms to seek care from either their
assigned local CHW or the nearest public sector HF. In-
dividuals that escorted patients who sought care were
also tested if they were identified as members of the
study clusters. During both active and passive visits, all
study participants found to be positive for malaria by
RDT received standard AL treatment for uncomplicated
malaria. Those found to be febrile and negative by RDT
through either active or passive testing systems were re-
ferred to the nearest healthcare facility. In both the ac-
tive and passive systems, the CHWs reported weekly
summaries via mobile phone short messaging system of
the number of patients tested, RDT test results, AL and
RDT stock status and the numbers of treatments of each
pack size (6, 12, 18 or 24 tablets) they had dispensed.
Table 1 Association of symptoms of illness with RDT
positivity, age and seasonalityiii iv
Symptom Passive surveillance Active surveillance
OR [95% CI]c Pd OR [95% CI]c Pd
Fever 5.98[5.79,6.16] <0.001 14.63[14.55,14.71] <0.001
History of fever 2.16[1.93,2.40] <0.001 2.86[2.77,2.95] <0.001
Headache 2.31[2.15,2.47] <0.001 6.83[6.77,6.90] <0.001
Cough 0.74[0.58,0.90] <0.001 1.85[1.77,1.93] <0.001
Diarrhoea 1.47[1.15,1.79] 0.017 2.04[1.86,2.21] <0.001
Vomiting 3.01[2.74,3.27] <0.001 6.61[6.43,6.80] <0.001
Chest pain 0.88[0.56,1.20] 0.447 1.47[1.31,1.64] <0.001
Breathing problems 1.78[−8.61,12.16] 0.914 7.99[6.47,9.52] 0.008
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The principal data sources for this study were the CHW
malaria registers and health facility reports sent to
NMCC through the malaria rapid reporting system plat-
form [66] via the Airtel™ mobile phone network in the
two districts. To ensure data quality and full disaggrega-
tion, the line-listed data from the malaria registers were
double-entered and verified, reconciled and then cleaned
following descriptive frequency analysis of the distribu-
tions of values for each variable. Statistical analysis was
accomplished using SPSS version 20 (IBM) and R ver-
sion 2.14.1 augmented with the lattice, Matrix and
LME4 packages.Other symptoms 0.87[0.46,1.28] 0.510 0.98[0.81,1.15] 0.809
iiic – odds ratio with 95% confidence intervals, d – p-value.
ivThe association of clinical symptoms with malaria infection as determined
by RDT positivity was determined by logistic regression with GLMMs
controlling for age and seasonality as fixed effects and for date, individual
nested in CHW and CHW nested in cluster location as random effects.Association of malaria infection with age, sex, symptoms,
interventions, cluster and season
Generalized linear mixed models (GLMM) were used to
evaluate the association between observed RDT-determined
malaria infection status as a binary dependent variable with
an intercept, age category (<1, 1 to 4, 5 to 10, 11 to 14, 15
to 24, 25 to 44 and >45 years of age), sex, access to an
LLIN, use of an LLIN, having slept in a house that had been
treated with IRS in the previous six months, and the three
seasons (hot and wet from December to April, cool and dry
from May to August, and hot and dry from September to
November) as categorical independent variables. All models
included household identity number nested within CHW
catchment nested within cluster, as well as date of partici-
pant contact, as random effects, with the exception one
model lacking an intercept in which cluster was treated as a
categorical independent variable to determine the mean
diagnostic positivity of each cluster. The final model pre-
sented in Additional file 1 was selected by building the
model through adding explanatory variables to the model
one at a time, assessing improvements of the goodness of
fit using log-likelihood tests and retaining only those pa-
rameters that either had significance in the model or which
significantly improved the goodness of fit as per principle of
parsimony [67].Association of malaria infection with clinical symptoms
While several symptoms were indeed positively associ-
ated with P. falciparum infection, these were excluded
from the final model that captures the effects of most of
the variables presented in Additional file 1 simply be-
cause they are an effect, rather than a cause, of malaria
so they cannot be regarded as underlying independent
determinants of malaria risk. Instead, the association of
these symptoms with malaria infection was assessed as
follows, using separate GLMMs treating the presence or
absence of each symptom as the binary dependent vari-
able and malaria infection diagnostic result as a binary,
categorical, independent explanatory variable (Table 1).Each model also included age, sex and season as add-
itional categorical independent variables and individual
study participants nested within CHW catchment,
nested again within clusters as random effects. Each
model was selected to include only variables, which were
significant or significantly improved the goodness of fit,
as described above for the models of malaria infection
risk (Additional file 1).
Cost per case diagnosed and treated
The approximate cost of diagnosis and treatment of mal-
aria parasite infection through either the CHW or health
facility systems was calculated separately. For the CHWs,
this was split into two arms: active and passive. The
costs incorporated into our calculations were personnel
time, RDTs, microscopy where available, anti-malarial
drugs and sundry maintenance, transport and consum-
ables. Personnel time included an assumed 30% full time
equivalent (FTE) contribution to malaria diagnosis and
treatment by all personnel based at the HF and the
CHWs were assumed to have allocated 90% and 10%
FTE contributions to the active and passive service de-
livery arms. The cost of diagnosis was estimated by the
multiplying the unit cost (US$0.31 per RDT and US
$1.30 per microscopy test) [68,69] of each diagnostic
method by the number of tests done. The cost of drugs
was estimated by multiplying the total number of treat-
ments dispensed by the average Zambian malaria
programme unit cost of US$1.38. Annual remuneration
costs for all the CHWs are calculated based on their
monthly remuneration of US$71.58 (ZMW 350) per
month per CHW and the number of person months for
which they were engaged over the course of the study.
Annual costs of remuneration for health facility staff
were collated from the medium term expenditure
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US$281,150 (ZMW 1,377,600). Total personnel and
other facility maintenance costs were calculated by div-
iding the total number of times all study participants/
patients were appropriately diagnosed and treated. Sub-
sequent estimates of cost per case diagnosed and treated
were made by adding personnel time, costs of diagnosis
and treatment per case and facility maintenance costs. It
was not possible to estimate capital costs for either the
CHW or health facility systems, so these were excluded
from these calculations. Calculations of directly observed
costs were based on those recorded over the six months
from April to September 2011 when all the CHW and
HF were fully functional but before IRS was introduced
as a possible confounding effect. A projected per capita
cost estimate for a year was then estimated by doubling
these six month cost estimates. Furthermore a projected
potential cost per capita for implementing such an
equivalent CHW programme but complete compliance
of the catchment population with monthly testing was
also calculated. Annual per capita cost estimates for the
actual and enhanced-participation scenarios were also
calculated for scenarios in which transmission is reduced
to levels where treatment costs were negligible.
Population attributable fraction of symptoms to malaria
infection
The proportion of cases of each specific clinical symp-
tom identified within the population by the CHWs that
could be attributed to RDT-detectable malaria infections
was estimated as follows [3]:
λ ¼ p R−1ð Þ=R
Where λ is the attributable fraction, p is the diagnostic
positivity and R is the odds ratio of symptom associated
with malaria infection. This formula was separately ap-
plied to both the active and passive surveillance data ob-
tained through the CHWs.
Ethical approval
Ethical approval was obtained from the University of
Zambia, Biomedical Research Ethics Committee (Refer-
ence 004-05-09) and the Research Ethics Committee of
the Liverpool School of Tropical Medicine (Approval
09.60). Authority to conduct the study was also obtained
from the Ministry of Health in Lusaka, Zambia.
Results
Rates of participation and testing through health facilities
and community health workers
From a combined catchment population of 77,754 for
Luangwa and Nyimba, there were approximately 75,791
outpatients visits attended to at the 14 enrolled HFs in2011. Seasonal patterns of testing for malaria at HFs
were roughly similar and peaked at approximately the
same time of the year in both districts, with an overall
mean rate of testing for malaria infection of 56%. Mean
monthly testing rates were 36.9% (range = 0% to 100%)
for patients in Luangwa and 69.3% (range =0% to 100%)
in Nyimba (Figure 2A and C) so the proportion of pa-
tients in which malaria was suspected and tested for was
approximately twice as high in Nyimba as Luangwa.
A total of 14 population clusters centred around these
HFs, with enrolled populations that ranged from 753 to
1,243, were established and followed up over a period of
one full calendar year in 2011 from January to December
for Luangwa District, and April to December for Nyimba
district. A total of eight and 12 monthly rounds of active
household visit surveys were conducted by each CHW
in Nyimba and Luangwa, respectively, to test and treat
all consenting residents within these population clusters.
A total population of 17,543 individuals participated by
consenting to testing during the active monthly house-
hold visits, of whom 20% were under the age of five.
During the same period a total of 3,804 individuals, of
whom 24% were under the age of five, sought care and
were tested when they self-reported to the CHW, the re-
sults of which were then recorded as a passive surveil-
lance indicator (Additional file 1). Slightly more females
participated in both the active and passive visits than
males (Additional file 1), presumably because females
were more accessible during the active household visits,
and sought care more frequently from CHWs through
their passive service provision role, than males because
they spent most of their time at home [70]. The CHWs
referred a total of 577 and 631 patients detected through
passive and active surveillance systems, respectively, to
the health facilities for further management. The main
reasons provided for referral were the inability by the
CHWs to manage some of the conditions presented to
them by the patients, RDT positive results for pregnant
women, lack of patient improvement while on malaria
treatment and insufficient AL stocks in the hands of that
CHW for him or her to provide treatment directly. Over
the same period 42,389 and 932 suspected malaria cases
were tested by RDT and microscopy, respectively, and
20,794 were treated for malaria through the health facil-
ities in these clusters.
Introduction of CHWs for screening and treating of
residents captured a higher proportion of the popula-
tions they covered than the HFs they were based near
to, overwhelmingly through active monthly visits to the
household rather than passive reporting (Figure 2A and C).
This can be readily explained by the fact that these 14 HFs
covered a total catchment population of 77,754 people,
equivalent to 58.8% of the combined population of the two
districts, while a total of 42 CHWs were assigned a total
Health Facilities
Community Health Worker
Passive testing of self reporting patients
Active testing of residents during monthly household visits
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Figure 2 Proportion of catchment population tested (A and C) and diagnostic positivity for malaria infection among residents (B and
D) in Luangwa (A and B) and Nyimba (C and D).
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tion of the two districts. The introduction of this CB exten-
sion of primary healthcare services had no obvious impact
upon attendance rates at health facilities in Luangwa, and
a simultaneous drop in HF attendance in Nyimba resem-
bled seasonality patterns from the previous year (Figure 2A
and C). Thus no obvious impact of CHW services upon
the rates of reporting of suspected malaria to the local
health facility was apparent.
The proportion of enrolled participants who actually
consented to testing during active household visits rose
rapidly and then peaked at approximately half during
March in Luangwa (Figure 2A) and June in Nyimba
(Figure 2C). The proportion of enrolled individuals who
sought care and were passively tested for infection by
CHWs was generally far lower, only exceeding 5% in an
early peak in Luangwa but not in Nyimba (Figure 2A
and C). In both CHW survey arms, older children (5–
14 years) and the adults (≥15 years) comprised the high-
est proportion of those tested while young children
(<5 years) comprised a minority, presumably becausethey comprise a small demographic proportion of the
overall population (Figure 3).
Overall, less than 20% of the enrolled population was
tested more than once by CHWs through either the active
or passive surveys but the mean number of tests per indi-
vidual (2.3) was much higher than the median (1 [range =
1 to 24]) because the frequency distributions for the num-
bers of times individuals were tested through either mech-
anism were highly skewed (Figure 4A). The average
number of tests per individual participant through both
surveillance systems combined was understandably some-
what higher in Luangwa (4.4) than in Nyimba (3.2) be-
cause they were operational for 12 months in the former
but only eight months in the latter. The number of passive
patient contacts per individual through self-reporting to
CHWs ranged from 0 to 24 times in both districts over
the course of the study period, with a median of only once,
and an average of 1.2 times per individual. The number of
active patient contacts per individual through monthly
household visits by CHWs ranged from 1 to 12 times in
both districts over the course of the study period, with a
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Figure 3 Age and proportion of covered population tested for malaria infection each month as contacted passively (A and B) and
actively (C and D) by community health workers in Luangwa (A and C) and Nyimba (B and D).
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http://www.malariajournal.com/content/13/1/128median of only once, and an average of 2.6 times per
individual.
Comparative rates of malaria infection diagnosis by
health facilities and community health workers
Overall, the majority of occasions when residents sought
care through the passive detection systems of the HFs
(44%) and CHWs (57.5%) did not have malaria parasite
infections (Figure 2B and D). Nevertheless from the total
study population, more than 14,000 uncomplicated
malaria infections were identified by CHWs over the
course of 2011 with the vast majority (84.1%) of these
being detected through the active household visits rather
than through self-reporting to a CHW for passively of-
fered service (Additional file 1). While the HFs detected
even more malaria infections over the course of the
same year (37,204), these were drawn from much larger
catchment populations so the overall rate of detection of
cases of malaria infection per head of population cov-
ered was highest for the active surveys of the CHWs,
followed by passive surveys at the HFs and CHWs
(1.16,0.40 and 0.14 diagnostically confirmed malaria
infections per person per year) (Table 3). The overallincidence rates for detected and diagnostically confirmed
malaria infections, broken down by district were 1.13
and 1.51 cases per person per year for Luangwa and
Nyimba, respectively.
The overall diagnostic positivity, or proportion of diag-
nostic tests which confirmed malaria infection, was gener-
ally far higher among patients seeking diagnosis and
treatment through the routine services offered passively
by either the HF or the CHWs than among those screened
actively through the monthly household visits of the
CHWs (Additional file 1, Figure 2B and D). This was
presumably because self-reporting patients obviously
present a sample that is strongly biased towards those
who are actually ill at the time. Diagnostic positivity
observed at the healthcare facilities fluctuated seasonally,
peaking at the end of the rainy season in April and May
and reaching its lowest point at the end of the dry season
in September and October, with a mean of 17.2% in
Luangwa (range 4.8% to 34.1%) and 31.0% in Nyimba
(range 8% to 67%). The wide range of diagnostic positivity
in these study sites is comparable to what has been ob-
served in other malarious parts of Zambia [71,72] and
may be considered reasonably representative of the range
6,000
7,000
8,000 A
Mean = 2.3
0
1,000
2,000
3,000
4,000
5,000
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
10
15
20
25
30
35 B
0
5
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
Figure 4 Frequency histogram of the number of study participant contacts for each total number of preceding malaria infection tests
by community health workers per individual study participant (A) and the relationship between the proportion of those participants
diagnosed as being infected and the cumulative number of diagnostic tests for malaria infection per individual participant (B).
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http://www.malariajournal.com/content/13/1/128of transmission across most endemic parts of the country.
Considerable geographical heterogeneity was also ob-
served in the diagnostic positivity rates obtained through
the CHWs, especially those from their active household
surveys that were less biased towards infected individuals,
with the lowest being in the two most urbanized clusters
of Luangwa District (Additional file 1). Seasonal patterns
of diagnostic positivity at HFs, expressed as the propor-
tion of all patients tested diagnostically with RDTs or mi-
croscopy who were confirmed to be infected, differed
appreciably between the two districts with no particularly
consistent similarities or dissimilarities from 2010 to 2011
(Figure 2B and C). The seasonality patterns of diagnostic
positivity among residents tested by CHWs closely paral-
leled those tested by HFs in Luangwa and even preceded
them by a month or two in Nyimba (Figure 2) where access
to HFs was more challenging, especially during the rains.Furthermore, the estimated mean diagnostic positivity of
both passive and active surveillance of the CHWs were
strongly and positively correlated with those observed
through passive surveillance at the HFs across both districts
(Figure 5) and were, therefore, highly consistent with each
other as measures of malaria infection. Interestingly, diag-
nostic positivity rates reported by CHWs were much more
closely associated with those reported by HFs in Luangwa
than in Nyimba (Figure 5) where access to HFs is far more
difficult for this more scattered population.
Demographic, geographic and vector control
determinants of malaria infection burden
Malaria infection among residents tested by the CHWs
was associated with age, sex, season, geographical loca-
tion and coverage with vector control in the form of
LLINs and IRS, as well as the number of times each
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http://www.malariajournal.com/content/13/1/128individual had been tested previously and, in most cases,
treated for malaria (Additional file 1). Malaria infection
burden among patients self-reporting to the CHW
through the passive surveys peaked in exactly the same
age category as those tested during their active monthly
household visits (Additional file 1), confirming that es-
sentially the same population was being monitored by
both systems. Risk of infection peaked in older children
and was least among infants and the oldest adults and
females were slightly at less risk than males (Additional
file 1). Malaria infection probability was far higher in the
hot and wet season, and the cool and dry season, than in
the hot and dry season (Additional file 1).
The majority of study participants who reported using
an LLIN when they were tested by a CHW (72% (2,738/
3,804) for passive contacts and 70.1% (12,295/17,543) for
active contacts) had lower diagnostic positivity, consist-
ent with the protective effect expected. However, indi-
viduals living in the 9 clusters that were treated with IRS
towards the end of 2011, whose houses were actually
sprayed, had higher diagnostic positivity, even when
time, location and household effects were controlled for
(Additional file 1). Rather than conclude that IRS actu-
ally increases malaria risk, it may be presumed that theseestimates from best-fit models are probably a spurious
artefact arising from endogeneity caused by logically and
deliberately biased deployment of IRS to areas within
each cluster with highest disease burden by the District
Medical Offices tasked with implementing malaria con-
trol activities. Specifically, the IRS teams in both districts
deliberately started spraying the most isolated villages at
the fringes of the enrolled population clusters first so
that these could be completed before arrival of the rains
and associated limited access.
Association of malaria infection with clinical symptoms of
illness
A substantial proportion of all residents who reported
no symptoms whatsoever were found to carry malaria
parasite infection; 12% (5,123/42,881) and 27% (286/
1,062) of the active and passive contacts, respectively.
Discussions with CHWs confirmed that essentially all
asymptomatics who were tested through passive con-
tacts were those friends, relatives and caregivers who
had escorted a patient to see the CHW and were also
tested during such a visit. The overall number and pro-
portion of all patient contacts which were classified as
asymptomatic malaria infection detected by CHWs was
approximately twice as high among residents tested
through in active surveillance [8.8% (5,123/58,500)] ra-
ther than passive [5.4% (286/5,261)]. The proportion of
confirmed malaria cases identified through active
monthly surveys by CHWs who apparently exhibited no
symptoms whatsoever was only 43% (5,123/11,851), con-
firming that most detectable malaria infections are
chronic, but nevertheless associated with substantial, if
non-severe, symptoms at the time they are surveyed.
Malaria infection was associated with all specifically
assessed symptoms, and even with the “other symptoms”
category among residents screened during active house-
hold visits by CHWs, and most of these associations
could also be detected using data collected passively
from self-reporting patients (Table 1). The symptoms
most strongly associated with malaria infection were
fever, a history of fever in the last month, headache and
vomiting, with the former being the highest reported in
both surveillance arms (Table 1). The reverse was also
found to be true as all symptoms were associated with
RDT-detected malaria infection in both active and pas-
sive CHW surveys, except for breathing problems and
sundry other symptoms, using the passive surveys data
with limited sample size (Table 1). More than half of all
cases of fever and vomiting, and more than a quarter of
all cases with history of fever, headache and diarrhoea,
among residents tested during active CHW visits to their
households were attributable to malaria infection (Figure 6).
The positive association of cough with detectable infection
in the active visits, contrasting with a negative association
AB
Figure 6 Fractions of risk for reported clinical symptoms which
are attributable to malaria infection detected by community
health workers through active (A) and passive (B)
contact events.
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http://www.malariajournal.com/content/13/1/128in passive surveys that is more difficult to rationalize
(Table 1, Figure 6), may reflect an interactive effect upon
patient reporting rather than the manifestation of the
symptom itself, resulting in under-reporting of cough
among patients reporting to CHWs because they were in-
fected with malaria.
Association of malaria infection status and clinical
symptoms of illness with malaria testing frequency
Only one study participant was tested 24 times by CHWs
during both active and passive visits combined. Diagnostic
positivity for malaria was negatively associated with the
number of times that participant had been previously
tested, and in most cases, treated (Additional file 1,
Figure 4B). For the small proportion of individuals who
received 12 tests during a single calendar year, diagnostic
positivity through active surveys was estimated to be 5.4%
in their last test, compared with 32% for those tested for
the first time. Diagnostic positivity was therefore propor-
tionally 83% lower for the 12th test of those who partici-
pated at least that often, and this trend towards lower
diagnostic positivity continued downward for who were
tested even more frequently (Figure 4B). A similar
phenomenon was observed with regard to manifestation of
symptoms, with much lower rates of occurrence observedfor all reported clinical symptoms except cough among
individuals who had been repeatedly tested and treated for
malaria (Figure 7). Interestingly, even when RDT-diagnosed
infection status is accounted for by adding this independent
variable to the models depicted in Figure 7, the number of
times an individual had been previously tested remained
predictive of fever (P <0.001), history of fever (P <0.001),
headache (P < 0.001), diarrhoea (P < 0.001), chest pain
(P < 0.001), breathing problems, vomiting (P < 0.001) and
other symptoms (P < 0.001). Taken at face value, these ob-
servations appear to suggest that screening and treatment
may not only reduce probability of infection with malaria at
detectable parasite densities (Figure 4B), but also persistent
sub-patent infections that contribute to symptoms of illness
despite parasite densities too low to be detected (Figure 7).
However, testing frequency was not assigned to distinct
treatment groups or experimentally controlled in any other
way so these associations are purely observational and
causality cannot be directly inferred. For example, these
observations might also be explained by co-association of
testing frequency, malaria infection and symptoms of illness
with unrecorded health-conscious behaviours that are not
accounted for in the model described in Additional file 1.
Indeed, the test results at first active visit did seem to
slightly influence of the number of subsequent tests so the
trends observed in Figures 4B and 7 should be cautiously
interpreted: individuals whose first test yielded a negative
result had a slightly greater mean number of tests over the
course of the study (4.65 ± 0.03 versus 4.11 ± 0.05, P < 0.001
by GLMM).
Despite the impressive negative association of repeated
testing and treatment with the probabilities of infection
and symptoms among individuals, no dramatic impact
upon these parasitological and clinical outcomes were
obvious and a total incidence rate of 1.7 detected infec-
tions per head of population persisted (Figure 2, Table 3).
As illustrated in Figure 4A, the mean number of times
participants were tested was 2.3, so even if the relationship
between number of preceding tests and diagnostic positiv-
ity is causal, rather than merely co-associated, too few
participants were tested regularly enough for any dramatic
impacts to be observed at population level: Those who
had the mean number of tests would be expected to main-
tain a mean diagnostic positivity of 23.7% at the end of the
year, only 17.9% lower proportionally than those tested
only once (Figure 4B). Even if direct impact of testing and
treatment upon infection probability is assumed, and
comprehensive monthly testing could be achieved in the
future, this would still be expected to leave sufficient levels
of parasitaemia at population level to maintain endemic
transmission (Figure 4A and B) [73]. The intensity of
persisting transmission reflected in the measured EIR,
despite considerable levels of vector control, is also
reflected in measured rates of re-infection among humans:
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http://www.malariajournal.com/content/13/1/128Over the course of the study period, CHWs detected as
many as eight malaria infections in a single study participant
detected through passive surveillance, while the maximum
was nine infections in a single participant as detected
through active surveillance (Figure 4A).
Adherence of CHWs to diagnosis and treatment
guidelines
Patterns of diagnosis and treatment differed between pa-
tients seeking care at HFs or from CHWs, as well as res-
idents consenting to being tested by CHWs during theirFigure 8 Community health worker and health facility staff treatmentactive household visits (Figure 8, Table 2). Adherence to
national guidelines for diagnosis and treatment were
generally good among CHWs with 78% of all contacts
that resulted in an RDT test being followed by an appro-
priate decision to treat or not (Figure 8). The remainder
was primarily accounted for by diagnostically confirmed
cases of malaria infection that could not be treated be-
cause the CHW had run out of the drug, and also be-
cause small proportions of patients were treated in the
absence of a diagnostic result or despite a negative diag-
nostic result (Figure 8, Table 2). More worryingly, onlyand diagnostic practice in relation to national guidelines.
Table 2 Compliance to diagnostic and treatment policy – Community based and facility based (April to September 2011)v
Facility based Community based Community & facility
based
Passive Passive Active Passive and active Passive and active
Al dispensed No Yes Total No Yes Total No Yes Total No Yes Total No Yes Total
Tested by Test result
Rdt Negative 11,024 3,046 14,070 1,518 16 1,534 24,878 517 25,395 26,396 533 26,929 374,20 3,579 40,999
Positive 0 15,306 15,306 111 1,260 1,371 7,012 10,149 17,161 7,123 11,409 18,532 7,123 26,715 33,838
Microscopy Pegative 204 55 259 n/a n/a n/a n/a n/a n/a n/a n/a n/a 204 55 259
Positive 0 262 262 n/a n/a n/a n/a n/a n/a n/a n/a n/a 0 262 262
Rdt or microscopy Negative 11,228 3,101 14,329 1,518 16 1,534 24,878 517 25,395 26,396 533 26,929 37,624 3,634 41,258
Positive 0 15,568 15,568 111 1,260 1,371 7,012 10,149 17,161 7,123 11,409 18,532 7,123 26,977 34,100
Not tested 17,541 3,158 20,699 185 3 188 2,845 18 2,863 3,030 21 3,051 20,571 3,179 23,750
Total 39,997 40,496 80,493 3,443 2,555 5,998 66,625 21,350 87,975 70,068 23,905 93,973 110,065 64,401 174,466
vTreatment practice based on confirmatory RDT result was assessed between April and September as this was the period of time when all the CHW based active
& passive surveillance and the health facility based passive system were all fully functional.
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http://www.malariajournal.com/content/13/1/12853% of patients attending HFs were tested and then
treated or not treated appropriately to the test result,
primarily because a substantial proportion were neither
tested nor treated but also because small proportions
were treated in the absence of a test or despite a nega-
tive test (Figure 8, Table 2). So, consistent with reports
from other settings in Zambia [41,42,46,74] and beyond
[49,75,76], the CHWs had greater adherence to policy
guidelines on treatment practices in relation to diagnos-
tic test results than specialist staff at HFs (Figure 8,
Table 2). The proportion of patient contacts resulting in
a negative RDT test result, or assessed only clinically
without a confirmatory diagnostic test, that were treated
with AL were both at least six times higher at HFs than
CHWs (Figure 8). CHW provision of treatment to patients
with a negative test result was twice as high in the active
compared with passive but in both cases this occurred
only very rarely. All confirmed cases of malaria infection
reporting to health facilities received treatment with AL
and the same was true for 92% of those identified passively
by CHWs but only 59% among those identified through
active household visits (Table 2, Figure 8). In most cases
where CHWs did not provide treatment for RDT-positive
patients, this was because they lacked AL and those pa-
tients were referred to the HFs to collect curative drugs.
Testing and treatment service delivery, cost and cost-
effectiveness
As detailed in Table 3, expenses associated with personnel
and commodities are important components of the overall
cost of providing malaria diagnosis and treatment services
through either HFs (49%) or CHWs (25%). Sundry trans-
port and maintenance expenses also contributed substan-
tially to the overall cost of the HFs but not the CHWs.
The overall cost of HFs was three-fold higher than the
CHW approach but was less expensive than CHWs perhead of population covered, because the HFs were assigned
to cover far larger catchment populations while the CHWs
simply provided far more frequent testing and treatment
service to each resident through the active surveys con-
ducted through monthly household visits (Table 3). If the
same frequency of testing were implemented in a pre-
elimination scenario [77,78] where improved vector control
reduced drug treatment requirements to negligible levels,
this would save only a quarter of the overall costs of provid-
ing these HF or CHW services. Because of the lower
personnel, transport and maintenance costs of the CHWs,
combined with their better compliance with national guide-
lines, both the passive and active services provided by the
CHWs were almost twice as cost-effective in terms of cost
per diagnostically confirmed case identified and treated.
If community participation could be dramatically im-
proved to ensuring the average resident is tested at least
once per month, and the trend observed in Figure 4B is
assumed to represent impact of frequent testing and
treatment upon infection status, the cost and cost-
effectiveness of detecting and treating this diminishing
case load would approximately double, even in a pre-
elimination scenario where improved vector control
would negate treatment costs (Table 3).
Discussion
Despite the fact that only a quarter of the covered resi-
dent population agreed to be tested in each monthly
round of household visits by the CHWs, these active
surveys by modestly remunerated paid CB staff identi-
fied >11,000 malaria parasite infections in a population
of <18,000 residents in a single calendar year, of whom
more than half were symptomatic in or around the time
they were visited and may not have otherwise sought
care. The far higher sensitivity with which these active
household surveys by the CHWs detect cases of malaria
Table 3 Observed and potential cost-effectiveness of cases appropriately diagnosed and treatedvi vii vii ix
Health facility Community based
Directly observed process indicators over 6 months Passive Active Total
Covered community based cluster or facility catchment 77754 17543 17543 17543
Diagnostic tests carried out over six months 29897 2652 42556 45208
Diagnostically confirmed and treated cases of malaria infection over 6 months 15568 1260 10149 11409
Diagnostically confirmed and treated malaria case per head population over 6 months 0.20 0.07 0.58 0.65
Diagnostic tests per head of population over 6 months 0.38 0.15 2.43 2.58
Directly observed costs over 6 months
RDT tests conducted 29,376 2,652 42,556 45,208
Cost per test (US$) 0.31 0.31 0.31 0.31
Total RDT cost (US$) 9,113 823 13,201 14,024
Microscopy tests 521 n/a n/a n/a
Cost per test (US$) 1.30 n/a n/a n/a
Total cost of microscopy (US$) 676 n/a n/a n/a
AL treatments 21,827 1,279 10,684 11,963
Cost per treatment (US$) 1.38 1.38 1.38 1.38
Total cost of AL (US$) 30,069 1,762 14,718 16,480
Total personnel costs (US$) 281,150 18,001 18,001 18,001
Time commitment (% FTE) 30 10 90 100
Personnel costs of malaria testing and treatment 84,345 1,800 16,201 18,001
Sundry maintenance, transport and running costs for six months (US$) 43,201 103 926 1,029
Total cost for Six months (US$) 167,404 4,488 45,046 49,533
Total non-treatment costs over 6 months (US$) 137,335 2,726 30,328 33,053
Projected annual summaries at observed rates of testing & treatment
Total cost per head of population covered per year (US$) 4.31 0.51 5.14 5.65
Total non-treatment costs per head of population covered per year (US$) 3.53 0.31 3.46 3.77
Total cost per confirmed case treated (US$) 10.75 3.56 4.44 4.34
Projected potential summaries at optimized rates of active testing & treatment
Total cost per head of population covered per year (US$) 10.68
Total non-treatment costs per head of population covered per year (US$) 6.25
Total cost per confirmed case treated (US$) 8.09
viUS$ 1 = ZMW 4.89, exchange rate has been rebased to fit current Zambian currency.
Source: http://www.boz.zm/(S(keg4bza3j0p4fx2uixtmnibq))/FinanciaMarkestReport.aspx. Accessed 1st October 2013.
viiFTE - Full Time Equivalent.
viiiIn the projected annual summaries, cost per head of population was calculated by dividing the total costs by the catchment population. The cost of non
treatment is the cost of only testing such as in an elimination scenario. The cost per confirmed case if the total costs divided by the diagnostically confirmed and
treated cases of malaria infection.
ixProjected potential summaries developed from assumptions that the HF and CHW passive will not change even in an optimized environment. Cost/head of
population calculated by addition to observed cost of an average 9 missed active visits per person and 2 passive visits per person by the cost of RDTs and
Treatment respectively. The cost per confirmed case treated is the total cost per head divided by the mean number of CHW detected infections per year of 1.3.
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http://www.malariajournal.com/content/13/1/128infection is also reflected in the observation that this
surveillance arm captured twice as high an incidence
rate as the passive surveillance activities of the HFs and
CHWs combined. The strong association of many symp-
toms, especially fever, headache and vomiting with mal-
aria infection, particularly among individuals tested
during active household visits by the CHWs, confirms
previous reports that illustrate just how inaccurate the
term asymptomatic is in relation to widespread chronicmalaria infections [79-81] that clearly cause very large
proportions of the overall burden of clinical illness in
the community (Table 1, Figure 7). Clearly a large pro-
portion of the population are infected with malaria, and
suffering from a range of mild symptoms of clinical ill-
ness as a consequence, but do not feel ill enough to re-
port to a HF or even to a nearby CHW to seek care. In
addition to representing a major proportion of overall
morbidity burden among the population, these chronic
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http://www.malariajournal.com/content/13/1/128infections also act as a reservoir for continued transmis-
sion [4,5,27,80,82]. Regularly scheduled household visits
by CHWs, who presumably will need to be paid for such
a full time commitment, may therefore be extremely
useful for identifying, treating and mapping the individ-
uals who harbour chronic malaria infections and consti-
tute the infectious reservoir that sustain transmission
[38,83,84].
However, as implemented in this study, even these
monthly active household visits, repeated on a continuous
monthly survey cycle, had no obvious impact on malaria
infection burden, possibly because most participants did
not consent to testing often enough to benefit from any
impact upon malaria infection and associated symptoms
that are suggested, but not proven by, Figures 4 and 7, re-
spectively. While the AL treatment used here has well-
documented gametocidal properties [85-88], the limited
sensitivity of RDTs or microscopy and considerable nat-
ural density fluctuations of circulating P. falciparum blood
stages mean that approximately half of all malaria infec-
tions are sub-patent and escape detection by a single test-
ing event [27,89,90]. Furthermore, mosquito-to-human
transmission remained remarkably high in the study area,
measured as a mean EIR of approximately 70 infectious
bites per unprotected person per year [57,58]. The most
likely explanation of the persistence of such intense trans-
mission, despite reasonably high rates of LLIN use, supple-
mented with IRS in selected clusters towards the end of
this study, is probably the emergence of pyrethroid resist-
ance among local populations of An. funestus [91]. The
high rates of re-infection suggested by these entomological
surveys are consistent with and confirmed by the high
rates of infection incidence [92] recorded here (Table 3)
despite the imperfect sensitivity of RDTs [93,94]. Given
the imperfect detection sensitivity of RDTs [93,94] and the
rapid rates of re-infection that can be expected in a setting
with such a high EIR [30,95-98], it is unsurprising that at
least monthly screening and treatment is required to
achieve dramatic reductions of malaria infection burden
(Figure 4B), associated symptoms (Figure 7), and presum-
ably transmission [27,99,100], even assuming these two
figures reflect genuine impact rather than mere associ-
ation. However, it is certainly encouraging that the appar-
ent impacts among residents consenting to such frequent
testing and treatment, which these associations suggest,
compare very well with simulations and field data from
annual mass screen and treat programmes [40], and even
simulations and field observations of year-long mass drug
administration programmes with treatment cycles of only
four or even two weeks [19]. It may also be encouraging
that, despite their known limited sensitivity, RDTs appear
to be sensitive enough to detect persistent malaria infec-
tions if each individual is tested often enough (Figure 4B)
so that the frequent sporadic surges of detectable para-sitaemia characteristic of P. falciparum are captured
[101,102]. If the observed association of parasitaemia with
testing and treatment (Figure 4B) reflects genuine impact,
this also suggests patient compliance with the AL treat-
ment regime used in this study was probably comparable
with high estimates (84.5%) from previous evaluations in
Zambia [103].
Beyond extending delivery of diagnostic and thera-
peutic services to the grass roots community level, the
CHWs also provided a remarkably informative source of
surveillance data, including the overall burden and dis-
tribution of malaria and associated clinical symptoms, a
number of important demographic and geographic de-
terminants of risk, and the rates utilization of preventive
interventions, such as IRS and ITNs. It is particularly
encouraging that, despite their known sensitivity limita-
tions, RDTs [93,94] appear to be more than adequate for
monitoring disease burden through CHW extension sys-
tems that can guide programme implementation. Latent
antigenaemia several weeks after successful clearance of
infection can cause false positive results when using
HRP2 based RDTs, and therefore over-prescription of
anti-malarial drugs [104-106], so it is possible that esti-
mates of cost and cost-effectiveness described in Table 3
may be improved upon with better diagnostic technol-
ogy. If scale up of such CHWs is affordable beyond this
research setting and could be scaled up across entire dis-
tricts, provinces or even whole countries, such routinely
collected data reported in disaggregated form from such
small population subdivisions could be invaluable at all
levels of programmatic monitoring and evaluation.
The costs of providing this CB extension of primary
health care services, to provide both active and passive
screening and treatment for malaria were substantive
(Table 3), corresponding to 11.1% of the annual per
capita health budget of Zambia in 2011 ($96) [107]. Fur-
thermore, to achieve the full potential of this service by
ensuring community-wide engagement in screening and
treatment on at least a monthly basis (Figure 4B), these
costs are likely to double, even if baseline levels of trans-
mission were reduced to pre-elimination levels so that
the costs of drug treatment were negated (Table 3). It is
highly unlikely, or desirable, that such a cadre of CHWs
would be mobilized to deal with surveillance and control
of malaria alone so these CB personnel would also be re-
quired to deal with uncomplicated forms of other com-
mon illnesses like diarrhoea and pneumonia [51,54,108].
Even the passively provided malaria diagnosis and treat-
ment services described here would need to be aug-
mented with a range of other clinical services to be
supported at programmatic level [51,54]. It is therefore
difficult to envisage CHWs effectively or sustainably
taking on such substantive commitments on a purely
voluntary basis with no remuneration whatsoever. Barely
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household surveys by the CHWs were accounted for by
the cost of their meagre remuneration, and this figure
would reduce to less than a fifth if the increased com-
modity costs of full compliance with monthly screening
and treatment were to be incurred through improved
community participation. Paying these CHWs is there-
fore not only likely to be essential to ensure their reten-
tion and effectiveness as full time agents of malaria
infection surveillance and control, it is also a relatively
minor fraction of the overall cost of actively delivering
extended CB primary healthcare services.
Apart from its observational design, the most obvious
limitation of this study is that the majority of enrolled
residents were tested and, where appropriate, treated far
less than once a month (Additional file 1, Figures 2A
and C, 3C and D, and 4A) as originally envisaged. Future
evaluations of CHWs, especially those engaged to con-
duct frequent active household surveys of their entire
assigned populations, should include operational re-
search studies to better understand and address the limi-
tations of service uptake by community members
observed in this study.Conclusions
The monthly active household visits to entire communi-
ties by CHWs equipped with existing field-compatible
diagnostic tools were not sufficient to eliminate the
human reservoir of malaria infection from this rural
African setting with intense transmission despite reason-
ably high LLIN/IRS coverage. However, observed nega-
tive associations between infection status and frequency
of testing and treatment suggest that dramatic impact
upon malaria parasite infection risk and associated dis-
ease burden may be achievable through far more regular
testing and treatment. Substantive alleviation of malaria
may be attainable and cost-effective if the substantial,
but not necessarily prohibitive, costs of implementing
frequent active CB surveys for chronic malaria infections
are affordable to national programmes and higher levels
of community participation in regular testing opportun-
ities are achievable.Additional file
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